Medical Weight Loss

12 – 16 Weeks Weight Management with GLP-1 Semaglutide in San Diego

If you are looking to shed an average of 10 to 30 pounds over a few months the Cryo Sculpting Lab’s Semaglutide Weight Loss Program is the answer. Sometimes we need a little push when diet + exercise alone don’t provide the results we’re looking for. This program is exclusively available at the Cryo Sculpting Lab in Point Loma and includes a simple regimen of injections or dissolvable tablets to kickstart your body and turn it into a fat burning machine. Ask about our telehealth program.

What is Semaglutide?

Semaglutide is a compounded formulation of GLP-1, glucagon-like peptide, that was approved in 2017 under the name Ozempic® as a treatment for improving glycemic control in patients with Type 2 diabetes. It works by increasing insulin production and lowers glucagon secretion as well as targets areas in the brain that regulate appetite and food intake. Originally used for diabetes and sold under the name Ozempic®. In June 2021, Semaglutide was approved by the FDA for non-diabetic weight loss.

Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced food cravings in addition to improved blood sugar levels. The greatest weight loss benefits were observed when Semaglutide was used in combination with lifestyle changes, such as improved diet and consistent exercise.

GLP-1 is a hormone produced in the small intestine that stimulates insulin sensitivity and inhibits glucagon secretion, thereby lowering blood sugar. Semaglutide is a compounded Bioidentical formulation of GLP-1.  It works by:

  • Delaying how quickly our stomachs digest food. Leading to a feeling of fullness and satisfaction with smaller meal sizes.
  • Slowing intestinal motility so you will feel fuller longer after meals.
  • Lowering blood sugars, in part by reducing the production of sugar in the liver.
  • Stimulating insulin secretion by the pancreas.

Who is not a candidate?

Patients with a history of;

  • Diabetic retinopathy, a type of damage to the eye from diabetes.
  • Disease of the gallbladder.
  • Acute inflammation of the pancreas.
  • Decreased kidney function.
  • Multiple endocrine neoplasia type 2.
  • Family history of medullary thyroid carcinoma.
  • Patients who are insulin-dependent diabetic and those prone to diabetic ketoacidosis.
  • Patients who are already on a GLP-1 medication.

A medical consultation and laboratory work by one of our experienced medical providers is required before starting the program.


  • Weight loss
  • Neuroprotective
  • Improved fertility
  • Treatment of PCOS
  • Smoking cessation
  • Cardiovascular benefits
  • Improved sleep


The most commonly reported side effects include nausea, vomiting, diarrhea, stomach pain, appetite loss, and constipation. The nausea will resolve as your body adjusts to the treatment.

Follow Us